NOVOMEDLINK™
  1. Activella®

    (estradiol/norethindrone acetate tablets)

  2. Vagifem®

    (estradiol vaginal tablets)

  3. GlucaGen® HypoKit®

    (glucagon [rDNA Origin] for injection)

  4. Levemir®

    (insulin detemir [rDNA origin] injection)

  5. Norditropin®

    (somatropin (rDNA origin) injection)

  6. NovoLog®

    (Insulin aspart [rDNA origin] injection)

  7. NovoLog® Mix 70/30

    (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])

  8. NovoSeven® RT

    Coagulation Factor VIIa (Recombinant) Room
    Temperature Stable

  9. NovoSeven®

    (Coagulation Factor VIIa [Recombinant])

Patient Assistance Program

The Novo Nordisk Patient Assistance Program (PAP) provides a lifeline for those who have difficulty affording their medications and meet the program qualifications by offering a 90-day supply of medication.

By logging in to the PAP website, you can check patient eligibility, enrollment status, and medication shipments online, 24/7, when its most convenient for you.


If you have patients currently enrolled in the PAP program, make a selection below:

If you have eligible patients who are not yet enrolled, download the following forms to get started:

Levemir®, NovoLog®, NovoLog® Mix 70/30, Norditropin®, Activella® 1.0 mg/0.5 mg and Activella® 0.5 mg/0.1 mg, and Vagifem® are registered trademarks of Novo Nordisk A/S. NovoSeven® RT is a registered trademark of Novo Nordisk Health Care AG. NordiCare® is a registered trademark of Novo Nordisk A/S, Denmark.